Literature DB >> 25184061

Case presentation - A five-year survival of the patient with glioblastoma brain tumor.

Hubert Urbańczyk1, Anita Strączyńska-Niemiec2, Grzegorz Głowacki1, Dariusz Lange2, Leszek Miszczyk1.   

Abstract

This paper presents an atypical case of a patient with brain tumor of the glioblastoma multiforme (GBM) type who achieved a 5-year survival. Some general information is provided including epidemiology, diagnostic and treatment procedures (surgery and radio-chemo-therapy), and prognosis of survival related to GBM. The course of the disease, including its main symptoms, individual reasons for the delay of adjuvant treatment, after the primary surgical treatment, 37-month period of the decease free survival, as well as comprehensive management after the tumor recurrence are also presented. Histopathology confirming the clinical diagnosis is discussed in a separate chapter.

Entities:  

Keywords:  Brain tumors; Glioblastoma; Radiotherapy; Survival; Treatment

Year:  2014        PMID: 25184061      PMCID: PMC4150096          DOI: 10.1016/j.rpor.2014.04.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  8 in total

1.  Risk of astrocytic brain tumors associated with occupational chemical exposures. A case-referent study.

Authors:  T L Thomas; P A Stewart; A Stemhagen; P Correa; S A Norman; M L Bleecker; R N Hoover
Journal:  Scand J Work Environ Health       Date:  1987-10       Impact factor: 5.024

2.  Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].

Authors:  Lisa M DeAngelis
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

3.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

4.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

5.  Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

Authors:  F F Lang; D C Miller; M Koslow; E W Newcomb
Journal:  J Neurosurg       Date:  1994-09       Impact factor: 5.115

6.  Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.

Authors:  J R Simpson; J Horton; C Scott; W J Curran; P Rubin; J Fischbach; S Isaacson; M Rotman; S O Asbell; J S Nelson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-05-20       Impact factor: 7.038

Review 7.  Epidemiology of primary brain tumors: current concepts and review of the literature.

Authors:  Margaret Wrensch; Yuriko Minn; Terri Chew; Melissa Bondy; Mitchel S Berger
Journal:  Neuro Oncol       Date:  2002-10       Impact factor: 12.300

8.  p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

Authors:  D J van Meyel; D A Ramsay; A G Casson; M Keeney; A F Chambers; J G Cairncross
Journal:  J Natl Cancer Inst       Date:  1994-07-06       Impact factor: 13.506

  8 in total
  2 in total

1.  Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.

Authors:  Andrew B Satterlee; Denise E Dunn; Donald C Lo; Simon Khagi; Shawn Hingtgen
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

2.  Metachronous medulloblastoma and glioblastoma: Implications for clinical and technical aspects of re-irradiation.

Authors:  Vivek Verma; Rajesh R Kulkarni; Abhijeet R Bhirud; Nathan R Bennion; Rodney D McComb; Chi Lin
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.